Comments
Commented by Fabian Lorenz on April 3rd, 2025 | 07:20 CEST
Stock set for 100% rally! Evotec, thyssenkrupp, Vidac Pharma - A golden April ahead?
Can shareholders look forward to a 100% price gain soon? If analysts have their way, this could be imminent for Evotec. However, shareholders must first mark an important date in April, as the medium-term share price performance is likely to be decided then. For Vidac Pharma, analysts see even greater upside potential, making the current price weakness an interesting entry opportunity. After all, the biotech company is making operational progress. One of the surprises of the current week is thyssenkrupp. The Company is benefiting from billions being spent in defense and infrastructure. Now, it could also benefit from Trump's tariff policies. Analysts recommend buying.
Read
Commented by Juliane Zielonka on April 3rd, 2025 | 07:10 CEST
Novo Nordisk, BioNxt Solutions, Bayer: Three ways to health and returns
The pharmaceutical industry is booming, and three companies are set to be in the spotlight in 2025: Novo Nordisk, BioNxt Solutions, and Bayer. A common goal unites all three: To improve the health of millions of patients through innovative approaches. Investors have the opportunity to participate in their success. While their strategies differ, their focus on research, new therapies, and growth makes them exciting for investors. Novo Nordisk stands out with its obesity drug Wegovy. It reduces the risk of heart disease by 57% – a potential game changer, as obesity is a major contributor to severe cardiovascular diseases. BioNxt Solutions is leveraging fresh capital and future technologies. The Company is developing novel drug delivery systems, including sublingual films, transdermal patches, and oral tablets for autoimmune diseases like multiple sclerosis. With CAD 2.5 million from a private placement, it is ready for the next step. Bayer is pushing ahead with its broad pharmaceutical offensive. In 2025, the Leverkusen-based company will launch drugs for the treatment of cardiovascular diseases, oncology, and women's health – areas with high medical demand and market potential.
Read
Commented by André Will-Laudien on April 2nd, 2025 | 09:05 CEST
Tesla is out; SMRs are in! Green hydrogen in focus at nucera, Nel ASA, Plug Power, First Hydrogen, and Oklo
Even if Donald Trump denies climate change, the international community still has hydrogen and alternative energies on the agenda. Within the new US administration, nuclear projects have been under discussion for several months, alongside an emphasis on fossil fuels. Small modular reactors (SMRs) are being discussed in this context. They can be planned and put into operation in a much shorter time and are highly flexible in their applications. In the US, Oklo is moving forward in this area, and the Canadian company First Hydrogen is also in the starting blocks to roll out its innovative solutions. This means that green hydrogen remains in focus. Which stocks are coming to the fore?
Read
Commented by Armin Schulz on April 2nd, 2025 | 07:20 CEST
dynaCERT: Government-backed, certified, profitable – Driving your returns green
The Ontario government is leading by example – and dynaCERT could be one of the beneficiaries. The Canadian cleantech company, known for its revolutionary HydraGEN™ technology, is receiving government support in a market that is hungry for solutions for more efficient mobility and measurable CO₂ reductions. In an era when climate goals and economic considerations can no longer be at odds, dynaCERT is positioning itself as a bridge between ecology and economy. A new player is emerging here in the billion-dollar market for emission certificates.
Read
Commented by Armin Schulz on April 2nd, 2025 | 07:10 CEST
Steyr Motors, Power Metallic Mines, BYD – From unique selling point to market leader
In the context of geopolitical tariffs and green transformation, drive technology, raw material extraction, and e-mobility are merging into key sectors. While US automotive tariffs are setting new rules from 2025, three players are driving systemic solutions: Steyr Motors, a pioneer in high-performance hybrid engines; Power Metallic Mines, which is setting ESG standards with carbon-neutral nickel; and BYD, which is dominating e-mobility through innovation. Their strategies – technological sovereignty, vertical integration, and resource-efficient ecosystems – demonstrate how the apparent contradictions between decarbonization and industrial reality can be overcome. Three companies, one mission: to shape the value chain of tomorrow.
Read
Commented by Armin Schulz on April 2nd, 2025 | 07:00 CEST
RENK – The armaments hype is waning. First Phosphate and Volkswagen are taking advantage of the upswing in electromobility!
The demand for armaments stocks is waning. Despite record orders for tank transmissions from the RENK Group and global security investments, the defense boom is flattening out - partly because these stocks have become fundamentally expensive. At the same time, electromobility is gathering pace: The EU predicts a 38% increase in the number of electric vehicles registered in 2025, driven by Germany's planned tax breaks and subsidies for hybrids. This surge requires raw materials to produce lithium iron phosphate batteries, which is where First Phosphate comes into play. Meanwhile, Volkswagen is currently exploring the production of military vehicles, but is also pushing into the market with new electric vehicles and charging systems. Investments for the future should flow into green technologies, not tank production.
Read
Commented by Mario Hose on April 1st, 2025 | 12:30 CEST
Insider Buying: Almonty Industries CEO buys again
Two purchases in just a few days - what is behind Lewis Black's confidence in his own company, and why could tungsten soon become the most strategically important metal in the Western world? In times of geopolitical tension, it is often the small signals that herald big things. On March 28 and again on March 31, 2025, Lewis Black, CEO of Almonty Industries Inc., announced that he had bought 50,000 shares of his own company on the stock exchange. Insider purchases like this are rarely a coincidence – they demonstrate conviction and deep confidence in the Company's future trajectory. For experienced investors, this is a strong signal: the man at the top truly believes in the story.
Read
Commented by André Will-Laudien on April 1st, 2025 | 07:20 CEST
Was that the Trump crash? Nevertheless, steeply upwards with Evotec, Bayer, BioNTech, Defence Therapeutics, or Valneva?
Since November 2024, Donald Trump has driven the markets sharply upward - his controversial new presidency was largely celebrated by investors. Now, his leadership feels somewhat unsettling, with fires seemingly being set again at every corner. The new president is acting more imperiously than ever, with Panama, Canada, and Greenland verbally on the agenda as the next US states. Meanwhile, the US administration is facing a considerable deficit, which is to be addressed by drastically reducing the size of the public sector and introducing tariffs. Unsurprisingly, interest rates are now rising sharply, which is a reason for weaker prices in the biotech sector. However, the sector has done its homework and is emerging from a three-year downturn. Are we now at buying levels?
Read
Commented by Fabian Lorenz on April 1st, 2025 | 07:10 CEST
Over 200% upside potential and a revenue surprise? Steyr Motors, D-Wave, and naoo shares
The current stock market phase is not for the faint-hearted. The price fluctuations of shares such as Steyr Motors, D-Wave, and social media newcomer naoo are severe. However, the latest price fluctuations also offer opportunities. Analysts see more than 200% upside potential in the Swiss technology company naoo. Driven by acquisitions, revenue and earnings are expected to rise sharply. D-Wave could surprise on the revenue side, as experts anticipate positive momentum from its latest partnership. And what is Steyr Motors doing? After the recent price fluctuations, BaFin may investigate. Major shareholder Mutares is also under scrutiny.
Read
Commented by Stefan Feulner on April 1st, 2025 | 07:00 CEST
BYD, MiMedia Holdings, Xiaomi – Interesting entry opportunities
The first quarter of the 2025 stock market year is history and has been sobering. With the election of Donald Trump last November, the markets started an impressive rally. The DAX, Dow Jones, and Bitcoin marked historic highs. However, these gains were wiped out in the following months by the imposition of punitive tariffs, escalating trade wars, and an uncertain geopolitical situation. Nevertheless, the consolidation has had some positive effects. In the technology sector, valuations that had become somewhat exaggerated have returned to a more normal level.
Read